We evaluated the potential antitumor effect of ML323, a selective inhibitor of USP1, in both a syngeneic s.c. CRC mouse model and a syngeneic orthotopic metastasis CRC mouse model. The gene discussed is USP1; the disease is colorectal carcinoma.